Free Trial
NASDAQ:MLAB

Mesa Laboratories (MLAB) Stock Price, News & Analysis

Mesa Laboratories logo
$67.75 +0.35 (+0.52%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$67.73 -0.02 (-0.03%)
As of 08/29/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Mesa Laboratories Stock (NASDAQ:MLAB)

Key Stats

Today's Range
$66.98
$68.18
50-Day Range
$57.44
$102.42
52-Week Range
$55.45
$155.12
Volume
102,083 shs
Average Volume
120,631 shs
Market Capitalization
$372.76 million
P/E Ratio
N/A
Dividend Yield
0.94%
Price Target
$113.50
Consensus Rating
Hold

Company Overview

Mesa Laboratories Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
66th Percentile Overall Score

MLAB MarketRank™: 

Mesa Laboratories scored higher than 66% of companies evaluated by MarketBeat, and ranked 343rd out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Mesa Laboratories has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Mesa Laboratories has only been the subject of 2 research reports in the past 90 days.

  • Read more about Mesa Laboratories' stock forecast and price target.
  • Earnings Growth

    Earnings for Mesa Laboratories are expected to grow by 9.00% in the coming year, from $8.00 to $8.72 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Mesa Laboratories is -483.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Mesa Laboratories is -483.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Mesa Laboratories has a P/B Ratio of 2.16. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Mesa Laboratories' valuation and earnings.
  • Percentage of Shares Shorted

    5.96% of the float of Mesa Laboratories has been sold short.
  • Short Interest Ratio / Days to Cover

    Mesa Laboratories has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Mesa Laboratories has recently increased by 23.06%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Mesa Laboratories has a dividend yield of 0.94%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Mesa Laboratories does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on earnings estimates, Mesa Laboratories will have a dividend payout ratio of 7.34% next year. This indicates that Mesa Laboratories will be able to sustain or increase its dividend.

  • Read more about Mesa Laboratories' dividend.
  • Percentage of Shares Shorted

    5.96% of the float of Mesa Laboratories has been sold short.
  • Short Interest Ratio / Days to Cover

    Mesa Laboratories has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Mesa Laboratories has recently increased by 23.06%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Mesa Laboratories has a news sentiment score of 1.39. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.09 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Mesa Laboratories this week, compared to 3 articles on an average week.
  • Search Interest

    1 people have searched for MLAB on MarketBeat in the last 30 days.
  • MarketBeat Follows

    2 people have added Mesa Laboratories to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Mesa Laboratories insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $296,507.00 in company stock.

  • Percentage Held by Insiders

    Only 4.90% of the stock of Mesa Laboratories is held by insiders.

  • Percentage Held by Institutions

    90.60% of the stock of Mesa Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Mesa Laboratories' insider trading history.
Receive MLAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MLAB Stock News Headlines

Mesa Laboratories Holds Annual Shareholder Meeting
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis.tc pixel
Mesa Laboratories Executes Previously-Announced Strategic Financing Plan
See More Headlines

MLAB Stock Analysis - Frequently Asked Questions

Mesa Laboratories' stock was trading at $131.87 at the beginning of 2025. Since then, MLAB stock has decreased by 48.6% and is now trading at $67.75.

Mesa Laboratories, Inc. (NASDAQ:MLAB) issued its earnings results on Tuesday, February, 4th. The medical instruments supplier reported $2.07 EPS for the quarter, topping analysts' consensus estimates of $1.41 by $0.66. Mesa Laboratories had a negative net margin of 0.26% and a positive trailing twelve-month return on equity of 24.49%.

Mesa Laboratories' top institutional investors include Conestoga Capital Advisors LLC (10.29%), Ranger Investment Management L.P. (3.89%), Geneva Capital Management LLC (3.62%) and Raymond James Financial Inc. (3.37%). Insiders that own company stock include John Bradley Schmieder, Gary M Owens, John Sakys, Shannon Hall and Brian David Archbold.
View institutional ownership trends
.

Shares of MLAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mesa Laboratories investors own include American Water Works (AWK), Waste Connections (WCN), AU Optronics (AUOTY), DiamondRock Hospitality (DRH), The RMR Group (RMR), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
2/04/2025
Record date for 6/16 Dividend
5/30/2025
Ex-Dividend for 6/16 Dividend
5/30/2025
Dividend Payable
6/16/2025
Record date for 9/15 Dividend
8/29/2025
Ex-Dividend for 9/15 Dividend
8/29/2025
Today
8/30/2025
Dividend Payable
9/15/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Electronic Equipment & Instruments
Current Symbol
NASDAQ:MLAB
CIK
724004
Employees
680
Year Founded
1982

Price Target and Rating

High Price Target
$160.00
Low Price Target
$67.00
Potential Upside/Downside
+67.5%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.14)
Trailing P/E Ratio
N/A
Forward P/E Ratio
8.47
P/E Growth
N/A
Net Income
-$1.97 million
Net Margins
-0.26%
Pretax Margin
3.74%
Return on Equity
24.49%
Return on Assets
9.03%

Debt

Debt-to-Equity Ratio
0.46
Current Ratio
0.66
Quick Ratio
0.47

Sales & Book Value

Annual Sales
$240.98 million
Price / Sales
1.55
Cash Flow
$12.25 per share
Price / Cash Flow
5.53
Book Value
$31.35 per share
Price / Book
2.16

Miscellaneous

Outstanding Shares
5,500,000
Free Float
5,232,000
Market Cap
$372.63 million
Optionable
Not Optionable
Beta
0.83

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:MLAB) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners